Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.

about

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.

P2860

Q54940383-7BA5C6CF-7B6D-424F-ADD5-2139B52468B7

P2860

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.

Item

http://www.wikidata.org/entity/Q50496500

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@en

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@nl

type

Item

label

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@en

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@nl

prefLabel

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@en

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@nl

P1476

Patients with Crohn's Disease ...... oss of Response to Infliximab.

@en

P2093

Angélique Cotteau-Leroy

http://www.w3.org/2001/XMLSchema#string

Julien Branche

http://www.w3.org/2001/XMLSchema#string

Loic Guerbau

http://www.w3.org/2001/XMLSchema#string

Louise Libier

http://www.w3.org/2001/XMLSchema#string

Medina Boualit

http://www.w3.org/2001/XMLSchema#string

Nicolas Duveau

http://www.w3.org/2001/XMLSchema#string

Pauline Wils

http://www.w3.org/2001/XMLSchema#string

Romain Gerard

http://www.w3.org/2001/XMLSchema#string

Stéphane Cattan

http://www.w3.org/2001/XMLSchema#string

Vincent Maunoury

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Predicting response to Anti-TNF Agents for the treatment of crohn's disease.

Neuropeptides, mesenteric fat, and intestinal inflammation.

Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.

Body mass index influences the response to infliximab in ankylosing spondylitis

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

P304

1853-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Nachury

Benjamin Pariente

Pierre Desreumaux

Delphine Staumont-Sallé

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28837519

http://www.w3.org/2001/XMLSchema#string

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.

about

P2860

P2860

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698